Episode 4: Marianne Clancy, Executive Director at Cure HHT

Episode 4 June 23, 2021 00:38:12
Episode 4:  Marianne Clancy, Executive Director at Cure HHT
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 4: Marianne Clancy, Executive Director at Cure HHT

Jun 23 2021 | 00:38:12

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.

Other Episodes

Episode 30

May 23, 2023 00:35:12
Episode Cover

Episode 30, Part Two: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH

"We have to rethink the sense of clinical research from the point of view that if we have the possibility to have markers that...

Listen

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 24

October 06, 2022 00:39:58
Episode Cover

Episode 24: Gadi Lachman, President and CEO, TriNetX

Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien,...

Listen